Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
mm decrease » nn decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
2 fold » _ fold (Expand Search), 5 fold (Expand Search)
2 mm » 1 mm (Expand Search), 5 mm (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
mm decrease » nn decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
2 fold » _ fold (Expand Search), 5 fold (Expand Search)
2 mm » 1 mm (Expand Search), 5 mm (Expand Search)
-
1
-
2
The rate of lariat formation is decreased two-fold by isoginkgetin treatment.
Published 2014“…(<b>C</b>) Isoginkgetin treatment leads to a decreased rate of lariat formation (* indicates <i>p</i> = 0.02) without affecting exon ligation or excised lariat degradation (<i>p</i> = 0.22, 0.08), with calculations as in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0089673#pone-0089673-g001" target="_blank">Fig. 1</a>. …”
-
3
Genes whose expression was decreased by 1 mM ouabain by more than 2-fold.
Published 2019“…<p>Genes whose expression was decreased by 1 mM ouabain by more than 2-fold.</p>…”
-
4
-
5
-
6
-
7
Resveratrol decreases PKM2 expression.
Published 2013“…<p>Resveratrol treatment decreases PKM2 mRNA in (A), HeLa; (B), HepG2 and (C), MCF-7; by approximately two-folds. β-actin was taken as endogenous control and normalized to PKM2 mRNA. …”
-
8
-
9
-
10
Corticosterone treatment decreases MMP-2 promoter activity.
Published 2012“…<p>Endothelial cells (1.0×10<sup>6</sup> cells) were plated in 35 mm<sup>2</sup> dishes coated with type I collagen and treated with 600 nM corticosterone for 48 hours. …”
-
11
-
12
GluN2A(D731N) decreases channel open probability.
Published 2017“…The di-heteromeric mutant (2A-D731N) and tri-heteromeric receptors with two-copies of the mutant subunit (D731N/D731N) showed a prolonged inhibition rate, reflecting a decreased channel open probability. …”
-
13
FTY720 treatment decreased tumor growth in a xenograft model of hepatoblastoma.
Published 2019“…<p>(A) HuH6 cells (2.5 x 10<sup>6</sup> cells in 25% Matrigel) were injected subcutaneously into the right flank of 6-week-old female athymic nude mice. …”
-
14
-
15
-
16
FTY720 decreased viability, proliferation, and motility and induced apoptosis in human hepatoblastoma cells.
Published 2019“…<p>(A) Following 24 hours of treatment with FTY720, the viability of HuH6 cells measured using the alamarBlue cell viability assay was significantly decreased (LD<sub>50</sub> = 8.4 μM, p ≤ 0.05). …”
-
17
-
18
-
19
-
20